US Stock MarketDetailed Quotes
DVA DaVita
- 162.750
- -1.180-0.72%
Close Oct 1 16:00 ET
- 162.850
- +0.100+0.06%
Post 17:07 ET
13.65BMarket Cap17.31P/E (TTM)
163.940High160.590Low620.15KVolume163.520Open163.930Pre Close100.80MTurnover1.40%Turnover Ratio21.93P/E (Static)83.90MShares166.04052wk High21.57P/B7.20BFloat Cap71.51052wk Low--Dividend TTM44.23MShs Float166.040Historical High--Div YieldTTM2.04%Amplitude0.687Historical Low162.536Avg Price1Lot Size
DaVita Stock Forum
Sign in to post a comment
1) $Apple (AAPL.US)$
2) $Bank of America (BAC.US)$
3) $American Express (AXP.US)$
4) $Coca-Cola (KO.US)$
5) $Occidental Petroleum (OXY.US)$
6) $The Kraft Heinz (KHC.US)$
7) $Chevron (CVX.US)$
8) $Moody's (MCO.US)$
9) $Chubb Ltd (CB.US)$
10) $DaVita (DVA.US)$
11) $MITSUBISHI MOTOR CORP (MMTOF.US)$
12) $Mitsui (8031.JP)$
13) $ITOCHU (8001.JP)$
2) $Bank of America (BAC.US)$
3) $American Express (AXP.US)$
4) $Coca-Cola (KO.US)$
5) $Occidental Petroleum (OXY.US)$
6) $The Kraft Heinz (KHC.US)$
7) $Chevron (CVX.US)$
8) $Moody's (MCO.US)$
9) $Chubb Ltd (CB.US)$
10) $DaVita (DVA.US)$
11) $MITSUBISHI MOTOR CORP (MMTOF.US)$
12) $Mitsui (8031.JP)$
13) $ITOCHU (8001.JP)$
8
2
DaVita's global expansion strategy, backed by strong local team investment, is set to make a lasting impact on healthcare communities. Their focus remains on providing exceptional care for kidney disease patients.
1
Legendary INvestor Warrent BUffett Portfolio
$Apple (AAPL.US)$ $Bank of America (BAC.US)$ $American Express (AXP.US)$ $Coca-Cola (KO.US)$ $CHERVON (02285.HK)$ $The Kraft Heinz (KHC.US)$ $Moody's (MCO.US)$ $DaVita (DVA.US)$ $CITIC BANK (00998.HK)$
$Apple (AAPL.US)$ $Bank of America (BAC.US)$ $American Express (AXP.US)$ $Coca-Cola (KO.US)$ $CHERVON (02285.HK)$ $The Kraft Heinz (KHC.US)$ $Moody's (MCO.US)$ $DaVita (DVA.US)$ $CITIC BANK (00998.HK)$
5
Analysts believe DaVita's strong Q4 financials and full-year outlook were driven by expected volume improvements and continued strong cost controls. However, some analysts maintain a cautious stance, waiting to see more proof points on volume improvement.
1
DaVita's shares are a bargain per the price multiple model. High beta indicates a potential fall in a bearish market, offering a prime buying opportunity. Expected profit growth promises a bright future, leading to higher cash flow and share valuation.
DaVita's current P/E ratio implies investors doubt the company's future growth prospects. Unobserved earnings threats may be hindering the positive outlook typically reflected in the P/E ratio.
1
The recent lack of insider transactions and substantial sale of shares by insiders doesn't bode well, despite insiders owning a substantial share of company stocks. Their actions could reflect their assessment of the company's value.
Warren Buffett is arguably the world's most famous investor, and his investment moves are closely followed. Each quarter, the company he runs, Berkshire Hathaway, discloses its current holdings to shareholders.
As of the third quarter of 2023, Warren Buffett's portfolio is composed of 45 stocks, with significant positions in several key industries. The top holdings include 50.04% in $Apple (AAPL.US)$, 9.03% in $Bank of America (BAC.US)$, 7.22% in $American Express (AXP.US)$, 7.15% ...
As of the third quarter of 2023, Warren Buffett's portfolio is composed of 45 stocks, with significant positions in several key industries. The top holdings include 50.04% in $Apple (AAPL.US)$, 9.03% in $Bank of America (BAC.US)$, 7.22% in $American Express (AXP.US)$, 7.15% ...
27
3
Columns Novo Nordisk Sets New Record High: Analyzing the Market Effects of Popular GLP-1 Weight Loss Drugs
The increasing demand for GLP-1 weight-loss medications indicates that in the next ten years, a significant number of Americans may lose hundreds of millions of pounds collectively. This shift in weight could cause a redistribution of trillions of dollars.
Last week, $Novo-Nordisk A/S (NVO.US)$ presented evidence of a speeding trend when it announced that the primary component of Ozempic and Wegovy, ...
Last week, $Novo-Nordisk A/S (NVO.US)$ presented evidence of a speeding trend when it announced that the primary component of Ozempic and Wegovy, ...
16
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
104028852 : good morning brianjh
104028852 : I m new baby just want to know ko dividend....us how much dollars..4.35..or us435.00